Le Lézard
Classified in: Health
Subjects: NPT, AVO

NCPA in Part D Rule Comments: End Retroactive Pharmacy DIR Fees


ALEXANDRIA, Va., Jan. 17, 2018 /PRNewswire-USNewswire/ -- In comments submitted in support of the Centers for Medicare & Medicaid Services' proposed 2019 Medicare Part D rule, the National Community Pharmacists Association has endorsed CMS' plan to consider assessing pharmacy DIR fees at point of sale.  The association offered input on several other provisions in the rule as well.

National Community Pharmacists Association Logo.

"We commend CMS for addressing in this proposed rule troublesome practices in the Part D program and encourage the agency to implement these provisions to produce greater convenience and savings for Medicare beneficiaries and greater transparency and fairness for pharmacies," said NCPA CEO B. Douglas Hoey, Pharmacist, MBA.

"NCPA and its allies urge CMS to stand firm against pushback from PBMs, who oppose having pharmacy price concessions rolled into the initial adjudication process for prescription drugs, even though doing so is in the interest of patients who need the Part D benefit the most."

NCPA's comments included the following points:

In addition to NCPA's comments, approximately 1,000 independent community pharmacist owners each submitted their own comments to CMS before the Jan. 16 deadline.

The National Community Pharmacists Association (NCPA®) represents the interests of America's community pharmacists, including the owners of more than 22,000 independent community pharmacies. Together they represent an $80 billion health care marketplace and employ more than 250,000 individuals on a full- or part-time basis. To learn more, go to www.ncpanet.org, visit facebook.com/commpharmacy, or follow NCPA on Twitter @Commpharmacy.

 

SOURCE National Community Pharmacists Association


These press releases may also interest you

at 06:21
Beyond2020, the flagship initiative launched by the Zayed Sustainability Prize, the UAE's pioneering award for sustainability and humanitarianism, today announced the deployment of AI-powered mammography services across Costa Rica to support the...

at 06:18
Surrey FA and Chelsea FC Foundation are proud to announce their collaborative effort once again to offer empowering coaching sessions to female refugees in the local community. These sessions will provide an opportunity for women to engage with...

at 06:05
BeiGene, Ltd. , a global oncology company, today announced that the European Commission (EC) has approved tislelizumab as a treatment for non-small cell lung cancer (NSCLC) across three indications, including first- and second-line use....

at 06:05
Vizient, Inc. hosted its inaugural Insight: Cell, Gene, and Specialty Pharmacy Symposium, bringing together leading healthcare providers, payers and manufacturers of high-cost, ultra-specialty pharmaceuticals along with other stakeholders to discuss...

at 06:05
SprintRay, the leader in dental 3D printing, unveiled the Company's most significant innovation to-date to over 250 dental professionals at 3DNext, their summit in Miami. The Midas Digital Press 3D Printer is poised to not only transform dental...

at 06:00
Panacea Healthcare Solutions,...



News published on and distributed by: